Company intelligence / Profile preview

ArtGene Therapeutics

Suzhou, Jiangsu, China

Ownership: Private
Development stage: Other

Overview

ArtGene Therapeutics is a clinical-stage biotechnology company focused on developing next-generation cell and gene therapies for solid tumors. The company leverages its proprietary Artificial Gene (ArtGene) platform, which utilizes synthetic biology to design optimized genetic circuits for enhanced therapeutic efficacy and safety. Their lead program, AGT-101, is a mesothelin-targeted CAR-T therapy currently in clinical development for various solid malignancies. ArtGene aims to overcome the barriers of the tumor microenvironment through innovative engineering of immune cells. The company is headquartered in Suzhou, China, and is supported by leading venture capital firms in the healthcare sector. It was founded by industry veterans with a track record of success in the CAR-T space, specifically from Legend Biotech.

Therapeutic areas: Oncology
Modalities: Cell therapyCAR-T cell therapyGene therapy
Industry: Biotech

Beyond the preview

Go deeper on ArtGene Therapeutics.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on ArtGene Therapeutics.

Explore the full profile